$4.03
-0.21-4.95%
Last update: Oct 30, 7:59 PM
Recursion Pharmaceuticals Inc (RXRX) Stock Price, Quote, News & History
RXRXNASDAQ
Cathie Wood's ARK dumps $18M of Twist Bioscience while buying Recursion, Veracyte and Intellia, extending its CRISPR bet to 50 sessions.
You can purchase shares of Recursion Pharmaceuticals (NASDAQ:RXRX) through any online brokerage.
Other companies in Recursion Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Recursion Pharmaceuticals has a consensus price target of $7.81.
The stock price for Recursion Pharmaceuticals (NASDAQ: RXRX) is $4.02 last updated October 30, 2026 at 7:59 PM EDT.
There are no upcoming dividends for Recursion Pharmaceuticals.
Recursion Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Recursion Pharmaceuticals.
Recursion Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically...
